World's Best Scientists 2026 revealed!
Clinical Cancer Research
H-index 112

Clinical Cancer Research

1078-0432

Published by: AACR

https://clincancerres.aacrjournals.org/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 26 2049 2327 109

Additional Metrics

Number of Best Scientists*: 3207
Documents by Best Scientists*: 2855
Top 100 Ranked Scientists*: 112
SCIMAGO H-index: 392
SCIMAGO SJR: 4.8
Impact Factor: 10.2

Overview

Top Research Topics at Clinical Cancer Research?

The scientific interests tackled in the journal are Cancer research, Cancer, Internal medicine, Pathology and Oncology. It explores issues in Cancer research which can be linked to other research areas like Cell growth, Cancer cell, Apoptosis, Immunology and In vivo. The Immunology study featured in the journal draws connections with the study of Cytotoxic T cell.

It investigates In vivo research which frequently intersects with Pharmacology. The Cancer study tackled is a key component of adjacent topics in the area of Lung cancer. The presented research on Internal medicine deals specifically with Gastroenterology but it also addresses topics in Pharmacokinetics.

Tumor progression, Gene expression and Adenocarcinoma are some topics wherein Pathology research discussed in it have an impact. The concepts on Oncology presented in Clinical Cancer Research can also apply to other research fields, including Clinical trial, Proportional hazards model, Disease, Biomarker (medicine) and Cohort. Clinical Cancer Research is mostly focused on Breast cancer, specifically Estrogen receptor.

  • Cancer research (39.64%)
  • Cancer (33.53%)
  • Internal medicine (32.49%)

What are the most cited papers published in the journal?

  • Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence (2931 citations)
  • Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria (2378 citations)
  • Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma (2182 citations)

Research areas of the most cited articles at Clinical Cancer Research:

The journal publications are mainly concerned with subjects like Cancer research, Cancer, Internal medicine, Pathology and Oncology. The Cancer research tackled in the published papers is interrelated with Pharmacology which concerns subjects like Toxicity and In vivo. The most cited publications address concerns in the field of Internal medicine by exploring it in line with topics in Endocrinology which intersect with Vascular endothelial growth factor subjects.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Gene

The previous edition focused in particular on these issues:

The concepts of Internal medicine, Oncology, Cancer research, Cancer and Immune system are tackled in the journal. It explores research in Gastroenterology and overlapping concepts in Pharmacokinetics to expand the discourse in Internal medicine. Issues in Oncology were discussed, taking into consideration concepts from other disciplines like Clinical trial, Chemotherapy, Biomarker (medicine), Breast cancer and Immunotherapy.

Clinical Cancer Research facilitates discussions on Cancer research that incorporate concepts from other fields like Cancer cell, Cell, Prostate cancer and In vivo. While Cancer is the key highlight in the journal, it also covered some subjects on Artificial intelligence and Machine learning. The study on Immune system presented in Clinical Cancer Research intersects with subjects under the field of Antibody.

The most cited articles from the last journal are:

  • Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma (32 citations)
  • Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial. (30 citations)
  • Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better? (29 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Clinical Cancer Research (based on the number of publications) are:

  • Gordon B. Mills (108 papers) published 5 papers at the last edition, 1 more than at the previous edition,
  • Ignacio I. Wistuba (82 papers) published 8 papers at the last edition, 1 more than at the previous edition,
  • Anil K. Sood (81 papers) published 10 papers at the last edition, 6 more than at the previous edition,
  • Kenneth C. Anderson (77 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • Mark J. Ratain (75 papers) published 2 papers at the last edition, 3 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical Cancer Research (based on the number of publications) are:

  • University of Texas MD Anderson Cancer Center (1787 papers) published 99 papers at the last edition, 15 more than at the previous edition,
  • Harvard University (1510 papers) published 138 papers at the last edition, 26 more than at the previous edition,
  • Memorial Sloan Kettering Cancer Center (1033 papers) published 92 papers at the last edition, 6 more than at the previous edition,
  • National Institutes of Health (790 papers) published 20 papers at the last edition, 1 less than at the previous edition,
  • Johns Hopkins University (703 papers) published 31 papers at the last edition, 4 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 5.09% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 38.80% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.47% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.54% of all publications and 37.19% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Education and Career Opportunities in Nursing Oncology

In the field of Oncology, nursing plays a pivotal role in providing quality patient care. Oncology nurses are involved in the care of individuals, families, and groups at risk for or diagnosed with cancer. They have a breadth of knowledge and expertise in managing the physical and psychological symptoms that accompany cancer, administering medication and treatment regimens, providing education on prevention and early detection, and offering support and counseling to patients and their families.

To pursue a career in oncology nursing, one must acquire a Bachelor of Science in Nursing degree, pass the National Council Licensure Examination (NCLEX-RN), and gain experience in an oncology setting. In addition, obtaining certification from the Oncology Nursing Certification Corporation can further enhance career prospects in this field.

If you are considering this fulfilling career path, we invite you to explore the top 10 best nursing schools in Delaware{anchor}. These institutions offer comprehensive nursing programs that provide the necessary knowledge and skills to excel in oncology nursing.

In conclusion, oncology nursing is a vital and rewarding profession in the healthcare sector. It offers varied opportunities for professional development and personal growth while making a significant impact in the lives of cancer patients and their families.

Top Publications

  • Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.

    Imran G House;Imran G House;Peter Savas;Peter Savas;Junyun Lai;Junyun Lai;Amanda X. Y. Chen;Amanda X. Y. Chen

    (2020)
    697 Citations
  • Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis.

    Laura M. Spring;Geoffrey Fell;Andrea Arfe;Chandni Sharma

    (2020)
    562 Citations
  • The Immunoscore: Colon Cancer and Beyond

    Helen K. Angell;Daniela Bruni;J. Carl Barrett;Ronald Herbst

    (2020)
    411 Citations
  • Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study.

    Wassim Abida;David Campbell;Akash Patnaik;Jeremy D. Shapiro

    (2020)
    361 Citations
  • Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer

    Adam J Schoenfeld;Joseph M Chan;Daisuke Kubota;Hiroki Sato

    (2020)
    295 Citations
  • A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

    Sandip Pravin Patel;Megan Othus;Young Kwang Chae;Francis Giles

    (2020)
    267 Citations
  • Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study.

    Michael J. Morris;Steven P. Rowe;Michael A. Gorin;Lawrence Saperstein

    (2021)
    253 Citations
  • Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

    Donghua Shi;Yaoping Shi;Ahmed O. Kaseb;Xingxing Qi

    (2020)
    252 Citations
  • Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy.

    Yuting Liu;Jon Zugazagoitia;Fahad Shabbir Ahmed;Brian S. Henick

    (2020)
    248 Citations
  • Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer.

    Aparna R. Parikh;Emily E. Van Seventer;Giulia Siravegna;Anna V. Hartwig

    (2021)
    243 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond traditional medicine, numerous online degree options can lead to rewarding paths. Aspiring nurses often wonder about the quickest routes to advance their qualifications. Programs like the how long to become a nurse practitioner provide valuable insights into timeframes and requirements for this advanced role.

If you are already a registered nurse, consider exploring the shortest rn to bsn program options available online, which offer a fast track to earning your bachelor’s degree while continuing to work.

For nurses with an Associate Degree in Nursing, bridge programs such as the adn to fnp pathway can help transition to becoming a Family Nurse Practitioner, opening doors to higher-level clinical responsibilities.

Moreover, non-nurses looking to enter the field can benefit from accelerated opportunities like msn direct entry programs online, which provide a direct path to a Master of Science in Nursing without prior nursing experience.

Exploring these online degree options allows flexibility and faster progression towards diverse healthcare careers, meeting the growing demand in the medical sector.

Best Scientists Contributing to This Journal

Recently Published Articles